PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 65 years old
- People who have experienced a traumatic event — such as something that involved death, serious injury, or sexual violence — within the last 2 weeks
- People who are currently experiencing high levels of PTSD symptoms related to that recent trauma, as measured by a standard questionnaire and symptom checklist
- People who have experienced a previous trauma in their lifetime but are currently showing low levels of PTSD symptoms related to that earlier event
- People who are currently taking psychiatric medications (such as antidepressants, antipsychotics, benzodiazepines, or anticonvulsants), as long as the dose has been stable for at least 6 weeks and will not change during the study
- People who are able and willing to give their informed consent to participate
Who may not be able to join:
- People who currently have thoughts of suicide with a plan or intent, or where a clinician judges there to be a likely risk of a suicide attempt in the next six months
- People who have ever been diagnosed with a psychotic disorder or bipolar disorder
- People who have been diagnosed with a neurological condition — such as epilepsy or a history of seizures, stroke, a brain tumour, cerebrovascular disease, a cerebral aneurysm, or a movement disorder — or who have ever lost consciousness for more than 5 minutes due to a head injury
- People who have had brain surgery, or who have metal particles in the eye or head (not including the mouth), a pacemaker or any lines inside the heart, implanted nerve stimulators, implants inside the skull (such as aneurysm clips, shunts, cochlear implants, or electrodes), or implanted medication pumps
- Women who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sanne van Rooij, PhD, Emory University
Phone: 404-251-8926
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Amygdala Reactivity During Fear Processing Pre- to Post TMS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.